388
Participants
Start Date
December 31, 2003
Study Completion Date
July 31, 2004
Celecoxib
200 mg oral capsule once daily with morning meal for 6 weeks
Placebo
Matched oral placebo for 6 weeks
Pfizer Investigational Site, Brooklyn
Pfizer Investigational Site, Binghamton
Pfizer Investigational Site, Johnstown
Pfizer Investigational Site, Washington D.C.
Pfizer Investigational Site, Wheaton
Pfizer Investigational Site, Arlington
Pfizer Investigational Site, Norfolk
Pfizer Investigational Site, Winston-Salem
Pfizer Investigational Site, Cary
Pfizer Investigational Site, Charleston
Pfizer Investigational Site, Longwood
Pfizer Investigational Site, Miami
Pfizer Investigational Site, Zephyrhills
Pfizer Investigational Site, Birmingham
Pfizer Investigational Site, New Tazewell
Pfizer Investigational Site, Bismarck
Pfizer Investigational Site, Bozeman
Pfizer Investigational Site, Morton Grove
Pfizer Investigational Site, Springfield
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, Wichita
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Denver
Pfizer Investigational Site, Boise
Pfizer Investigational Site, Boise
Pfizer Investigational Site, Buena Park
Pfizer Investigational Site, Portland
Pfizer Investigational Site, Eugene
Pfizer Investigational Site, Seattle
Pfizer Investigational Site, Trenton
Pfizer Investigational Site, New York
Pfizer Investigational Site, Duncansville
Pfizer Investigational Site, Warwick
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INDUSTRY